FISH Protocol for Myotonic Dystrophy Type 1 Cells

Arnaud F Klein1,2,3, Ludovic Arandel1,2,3, Joelle Marie1,2,3

  • 1Centre de Recherche en Myologie, Sorbonne Univeristé, Paris, France.

Insights

Researchers developed new methods to detect toxic RNA foci in myotonic dystrophy type 1 (DM1) cells. These techniques visualize expanded CUG repeats and their interaction with the MBNL1 splicing factor, aiding disease understanding.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Background:

  • Myotonic dystrophy type 1 (DM1) is an RNA-dominant disease characterized by expanded CUG repeats in DMPK transcripts.
  • These mutant transcripts form nuclear foci that sequester the MBNL1 splicing factor, a key pathological hallmark.
  • Understanding the spatial relationship between CUG repeat RNA and MBNL1 is crucial for DM1 pathogenesis.

Purpose of the Study:

  • To describe robust fluorescent in situ hybridization (FISH) techniques for detecting expanded CUG repeat RNA and DMPK transcripts.
  • To establish a combined FISH and immunofluorescence protocol for visualizing MBNL1 colocalization with nuclear CUGexp-RNA foci.
  • To provide tools for studying the molecular mechanisms underlying DM1.

Main Methods:

  • Fluorescent in situ hybridization (FISH) was employed to detect specific RNA transcripts.
  • FISH was optimized to visualize expanded CUG repeats (CUGexp) and total DMPK transcripts.
  • A dual-labeling protocol combining FISH with immunofluorescence was developed to assess MBNL1 protein localization relative to CUGexp-RNA foci.

Main Results:

  • Successful detection of nuclear CUGexp-RNA foci in DM1 cells using FISH.
  • Visualization of DMPK transcripts in both DM1 and wild-type (WT) cells.
  • Demonstrated colocalization of the MBNL1 splicing factor with CUGexp-RNA foci in DM1 patient cells.

Conclusions:

  • The described FISH and FISH/immunofluorescence methods are effective for studying DM1 at the cellular level.
  • These techniques enable the direct visualization of key pathogenic elements, including CUGexp-RNA foci and MBNL1 sequestration.
  • The developed protocols offer valuable tools for further research into DM1 pathology and potential therapeutic strategies.